Bayer has won the auction for Merck & Co's consumer care business with a cash offer of $14.2bn. The companies also plan to collaborate in the field of sGC (soluble guanylate cyclase) modulators, for which Merck will make an upfront payment to Bayer of $1bn.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?